{"organizations": [], "uuid": "177f9b271fa23815e546887f8ba63e250bcd986e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-collegium-reports-q4-loss-per-shar/brief-collegium-reports-q4-loss-per-share-0-54-idUSASB0C998", "country": "US", "domain_rank": 408, "title": "BRIEF-Collegium Reports Q4 Loss Per Share $0.54", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-07T23:12:00.000+02:00", "replies_count": 0, "uuid": "177f9b271fa23815e546887f8ba63e250bcd986e"}, "author": "", "url": "https://www.reuters.com/article/brief-collegium-reports-q4-loss-per-shar/brief-collegium-reports-q4-loss-per-share-0-54-idUSASB0C998", "ord_in_thread": 0, "title": "BRIEF-Collegium Reports Q4 Loss Per Share $0.54", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "collegium pharmaceutical inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 7, 2018 / 9:15 PM / in 9 minutes BRIEF-Collegium Reports Q4 Loss Per Share $0.54 Reuters Staff March 7 (Reuters) - Collegium Pharmaceutical Inc: * COLLEGIUM REPORTS FOURTH QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE * Q4 LOSS PER SHARE $0.54 * COLLEGIUM PHARMACEUTICAL - BELIEVE EXISTING CASH RESOURCES WILL FUND OPERATING EXPENSES, DEBT SERVICE AND CAPEX REQUIREMENTS INTO 2020  ", "external_links": [], "published": "2018-03-07T23:12:00.000+02:00", "crawled": "2018-03-07T23:33:26.013+02:00", "highlightTitle": ""}